NCT03909048

Brief Summary

This study will examine the effectiveness of one of two psychoeducation treatments on chronic low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 9, 2019

Completed
22 days until next milestone

Study Start

First participant enrolled

May 1, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

October 31, 2019

Status Verified

October 1, 2019

Enrollment Period

4 months

First QC Date

April 5, 2019

Last Update Submit

October 30, 2019

Conditions

Keywords

Chronic PainLow Back Pain

Outcome Measures

Primary Outcomes (5)

  • Pain Intensity as assessed by Numeric Rating Scale

    The Numeric Rating Scale (NRS) measures pain intensity measured via 0-10 numeric rating scale. 0 = No Pain - 10 = Worst Possible Pain Range of scores: 0-10

    Baseline - Final assessment (average 1 week post treatment)

  • Present Pain Intensity

    Present Pain Intensity (PPI) assesses present pain intensity on a scale of 0 (no pain) to 5 (excruciating)

    Baseline - Final assessment (average 1 week post treatment)

  • Present Pain Rating

    Pain Rating Index (PRI) is assessed by 15 questions assessing pain in the sensory and affective dimensions. Items rate from 0 (none) to 3 (severe) on degree to which the words apply to pain. Score Range: 0-45

    Baseline - Final assessment (average 1 week post treatment)

  • Pain Chronicity assessed by the Graded Chronic Pain Scale

    Pain Chronicity is assessed by the Graded Chronic Pain Scale (GCPS). The GCPS is 7 questions with 3 sub-scales (Characteristic pain intensity, disability score, and disability points). Scoring: Characteristic Pain Intensity: is a 0 to 100 score derived from Questions 1 through 3: Mean (Pain Right Now, Worst Pain, Average Pain) X 10. Disability Score: is 0 to 100 score derived from Questions 4 through 6: Mean (Daily Activities, Social Activities, Work Activities) X 10 Disability Points: Add the indicated points for Disability Days (Question 7) and for Disability Score (0-6). Items rate from 0 to 10 with 0 referencing no pain/interference/change and 10 referencing pain as bad as could be/unable to carry out any activities/extreme change.

    Baseline - Final assessment (average 1 week post treatment)

  • Daily Pain Monitoring: 10 point scale

    Daily pain monitoring defined as daily pain intensity and daily pain interference monitoring is two questions asked daily on a 10 point scale assessing daily pain and how much pain had interfered with day to day activities. Pain: Over the past 24 hours, how would you rate your back pain on average? (0=No Pain; 10=Worst Imaginable Pain) Interference: Over the past 24 hours, how much did pain interfere with your day-to-day activities? (0=No Interference; 10 = A great deal of interference)"

    Baseline - Final assessment (average 1 week post treatment)

Secondary Outcomes (14)

  • Back Disability as assessed by the Roland Morris Disability Questionnaire

    Baseline - Final assessment (average 1 week post treatment)

  • Depressive symptoms as assessed by the Center for Epidemiologic Studies Depression Scale

    Baseline - Final assessment (average 1 week post treatment)

  • Pain Catastrophizing as assessed by the Pain Catastrophizing Scale

    Baseline - Final assessment (average 1 week post treatment)

  • Pain-related fear of movement as assessed by the Tampa Scale Kinesiophobia

    Baseline - Final assessment (average 1 week post treatment)

  • Mood and Affect as assessed by the Positive and Negative Affect Scale

    Baseline - Final assessment (average 1 week post treatment)

  • +9 more secondary outcomes

Study Arms (2)

Interactive Psycho-education

EXPERIMENTAL

Interactive psycho-education using interactive dashboard.

Behavioral: Interactive - Psychoeducation

Psycho-education

PLACEBO COMPARATOR

Non-interactive psycho-education not using interactive dashboard.

Behavioral: Non-interactive Psychoeducation

Interventions

Individuals will receive interactive psychoeducation in the lab over the course of a week period. Each session will take approximately 30 minutes.

Interactive Psycho-education

Individuals will receive non-interactive psychoeducation over the course of a week period. Each session will take approximately 30 minutes.

Psycho-education

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • report having low back pain for more than three months and at least half the days in the past 6 months
  • be 18-65 years of age,
  • have scores higher than 37 on the Tampa Scale of Kinesiophobia,

You may not qualify if:

  • medical conditions other than back pain that significantly impair movement (e.g., arthritis)
  • confirmed/suspected pregnancy
  • pending litigation related to an episode of low back pain
  • significant impairment in vision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

MeSH Terms

Conditions

Chronic PainLow Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBack Pain

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participant, statistician, and outcomes assessor are blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 5, 2019

First Posted

April 9, 2019

Study Start

May 1, 2019

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

October 31, 2019

Record last verified: 2019-10

Locations